会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity
    • 具有选择性雌激素活性的16,17-碳环缩合类固醇化合物
    • US07868193B2
    • 2011-01-11
    • US10297706
    • 2001-05-01
    • Hubert Jan Jozef Loozen
    • Hubert Jan Jozef Loozen
    • C07J1/00A61K31/56
    • C07J53/002
    • The invention discloses a steroid compound having the formula (1), wherein dotted bonds represent optional double bonds; R6 is H, ═CH2, or —CH3, or —CH2—CH3; R7 is H, C1-4-alkyl, C2-5 alkenyl or C2-5-alkynyl, wherein the alkyl, alkenyl or alkynyl group may be substituted with 1 to 3 halogen atoms independently chosen from the group of fluorine or chlorine atoms; R11 is H, C1-4-alkyl, C2-4-alkenyl, C2-4-alkynyl or C1-4-alkylidene, wherein the alkyl, alkenyl, alkynyl or alkylidene group may be substituted with 1-3 halogen atoms independently chosen from the group of fluorine or chlorine atoms; E represents together with carbon atoms 16 and 17 of the steroid skeleton a four to seven-membered ring, said ring being α and in cis-configuration with respect to the steroid skeleton, optionally comprising one or two endocyclic bonds; or a prodrug thereof. Such compounds can be used in therapy and for methods for selective modification of the activity of estrogen receptors.
    • 本发明公开了具有式(1)的类固醇化合物,其中虚线键代表任选的双键; R6是H,= CH2或-CH3,或-CH2-CH3; R 7是H,C 1-4 - 烷基,C 2-5烯基或C 2-5炔基,其中烷基,烯基或炔基可以被独立地选自氟或氯原子的1至3个卤素原子取代; R 11为H,C 1-4 - 烷基,C 2-4 - 烯基,C 2-4 - 炔基或C 1-4亚烷基,其中烷基,烯基,炔基或亚烷基可以被1-3个独立地选自 该组氟或氯原子; E与类固醇骨架的碳原子16和17一起为4至7元环,所述环为α并且相对于类固醇骨架为顺式构型,任选包含一个或两个内环键; 或其前药。 这些化合物可用于治疗和选择性修饰雌激素受体活性的方法。
    • 7. 发明申请
    • 16, 17-CARBOCYCLIC CONDENSED STEROID COMPOUNDS HAVING SLECTIVE ESTROGENIC ACTIVITY
    • 具有选择性雌激素活性的16,17-碳环稠合的甾族化合物
    • US20110224183A1
    • 2011-09-15
    • US13112184
    • 2011-05-20
    • Hubert Jan Jozef Loozen
    • Hubert Jan Jozef Loozen
    • A61K31/567C07J53/00A61P15/18A61P19/10A61P5/30A61P35/00C12N5/00
    • C07J53/002
    • The invention discloses a steroid compound having the formula (1): wherein dotted bonds represent optional double bonds; R6 is H, ═CH2, or —CH3, or —CH2—CH3; R7 is H, C1-4-alkyl, C2-5 alkenyl or C2-5-alkynyl, wherein the alkyl, alkenyl or alkynyl group may be substituted with 1 to 3 halogen atoms independently chosen from the group of fluorine or chlorine atoms; R11 is H, Cl1-4-alkyl, C2-4-alkenyl, C2-4-alkynyl or C1-4-alkylidene, wherein the alkyl, alkenyl, alkynyl or alkylidene group may be substituted with 1 to 3 halogen atoms independently chosen from the group of fluorine or chlorine atoms; E represents together with carbon atoms 16 and 17 of the steroid skeleton a four to seven-membered ring, said ring being α and in cis-configuration with respect to the steroid skeleton, optionally comprising one or two endocyclic bonds; or a prodrug thereof. Such compounds can be used in therapy and for methods for selective modification of the activity of estrogen receptors.
    • 本发明公开了具有式(1)的类固醇化合物:其中虚线键代表任选的双键; R6是H,= CH2或-CH3,或-CH2-CH3; R 7是H,C 1-4 - 烷基,C 2-5烯基或C 2-5炔基,其中烷基,烯基或炔基可以被独立地选自氟或氯原子的1至3个卤素原子取代; R 11是H,C 1-4 - 烷基,C 2-4 - 烯基,C 2-4 - 炔基或C 1-4 - 亚烷基,其中烷基,烯基,炔基或亚烷基可以被1至3个独立地选自 该组氟或氯原子; E与类固醇骨架的碳原子16和17一起为4至7元环,所述环为α并且相对于类固醇骨架为顺式构型,任选包含一个或两个内环键; 或其前药。 这些化合物可用于治疗和选择性修饰雌激素受体活性的方法。